Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

NCT00528723 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchial Asthma

Interventions

DRUG: salbutamol 100 mcg
DRUG: BDP/salbutamol HFA pMDI
DRUG: BDP/salbutamol CFC pMDI

Sponsor

Chiesi Farmaceutici S.p.A.